C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency

  • US 10,105,423 B2
  • Filed: 12/11/2017
  • Issued: 10/23/2018
  • Est. Priority Date: 03/15/2013
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical composition comprising C1 esterase inhibitor, sodium citrate, and having a pH ranging from 6.5-8.0, wherein the C1 esterase inhibitor has a concentration of about 500 U/mL, and wherein the C1 esterase inhibitor comprises the amino acid sequence of residues 23 to 500 of SEQ ID NO:

  • 1.

View all claims

    Thank you for your feedback